Table of contents

Clinical and epidemiological research

• Extended report: The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study (9 March, 2011) Free

  Jesper Lindhardsen, Ole Ahlehoff, Gunnar Hilmar Gislason, Ole Rintek Madsen, Jonas Bjerring Olesen, Christian Torp-Pedersen, Peter Riis Hansen
• Extended report: Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative (2 May, 2011)

  L Gossec, S Paternotte, G J Aanerud, A Balanescu, D T Boumpas, L Carmona, M de Wit, B A C Dijkmans, M Dougados, M Englbrecht, F Gogus, T Heiberg, C Hernandez, J R Kirwan, E Martin Mola, M Matucci Cerinic, K Otsa, G Schett, M Scholte-Voshaar, T Sokka, G von Krause, G A Wells, T K Kvien
• Extended report: Prevalence of spondyloarthritis and its subtypes in southern Sweden (2 February, 2011)

  E Haglund, A B Bremander, I F Petersson, B Strömbeck, S Bergman, L T H Jacobsson, A Turkiewicz, P Geborek, M Englund
• Extended report: Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort (1 February, 2011)

  Mohammed Z Cader, Andrew Filer, Jonathan Hazlehurst, Paola de Pablo, Christopher D Buckley, Karim Raza
• Extended report: The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study (1 February, 2011)

  W G Dixon, A Kezouh, S Bernatsky, S Suissa
• Extended report: SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus (21 February, 2011)

  J G Hanly, M B Urowitz, D Jackson, S C Bae, C Gordon, D J Wallace, A Clarke, S Bernatsky, A Vasudevan, D Isenberg, A Rahman, J Sanchez-Guerrero, J Romero-Diaz, J T Merrill, P R Fortin, D D Gladman, I N Bruce, K Steinsson, M Khamashta, G S Alarcón, B Fessler, M Petri, S Manzi, O Nived, G Sturfelt, R Ramsey-Goldman, M A Dooley, C Aranow, R Van Vollenhoven, M Ramos-Casals, A Zoma, K Kalunian, V Farewell, for the Systemic Lupus International Collaborating Clinics (SLICC)
• Extended report: EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome (22 February, 2011)

  Raphaèle Seror, Philippe Ravaud, Xavier Mariette, Hendrika Bootsma, Elke Theander, Arne Hansen, Manel Ramos-Casals, Thomas Dörner, Stefano Bombardieri, Eric Hachulla, Johan G Brun, Aike A Kruize, Sonja Praprotnik, Matija Tomsic, Jacques-Eric Gottenberg, Valerie Devauchelle, Salvatore Devita, Cristina Vollenweider, Thomas Mandl, Athanasios Tzioufas, Steven Carsons, Alain Saraux, Nurhan Sutcliffe, Claudio Vitali, Simon J Bowman
• Extended report: Predicting the outcome of ankylosing spondylitis therapy (14 March, 2011)

  Nathan Vastesaeger, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, Ben Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes, Joachim Sieper, Jürgen Braun
• Extended report: Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI (1 March, 2011)

  Lukas Martin Wildi, Jean-Pierre Raynauld, Johanne Martel-Pelletier, André Beaulieu, Louis Bessette, Frédéric Morin, François Abram, Marc Dorais, Jean-Pierre Pelletier
• Extended report: Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study (2 March, 2011)

  J Antonio Aviña-Zubieta, Michal Abrahamowicz, Hyon K Choi, M Mushfiqur Rahman, Marie-Pierre Sylvestre, John M Esdaile, Diane Lacaille
• Extended report: Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial (17 March, 2011)

  Vibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, Philip Mease, Gerd R Burmester, Falk Hiepe, Dinesh Khanna, Enkeleida Nikaï, Geoffroy Coteur, Michael Schiff
• Extended report: Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial (11 March, 2011)

  Robert F Spiera, Jessica K Gordon, Jamie N Mersten, Cynthia M Magro, Mansi Mehta, Horatio F Wildman, Stacey Kloiber, Kyriakos A Kirou, Stephen Lyman, Mary K Crow
• Extended report: How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? (15 March, 2011)

  Martin Neovius, Julia F Simard, Johan Askling, for the ARTIS Study Group
• Extended report:

  Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris

  (23 February, 2011)

  John Bowes, Steve Eyre, Edward Flynn, Pauline Ho, Salma Salah, Richard B Warren, Helena Marzo-Ortega, Laura Coates, Ross McManus, Anthony W Ryan, David Kane, Eleanor Korendowych, Neil McHugh, Oliver FitzGerald, Jonathan Packham, Ann W Morgan, Christopher E M Griffiths, Ian N Bruce, Jane Worthington, Anne Barton
• Extended report: Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study (6 March, 2011)

  Mary A De Vera, Hyon Choi, Michal Abrahamowicz, Jacek Kopec, Maria Victoria Goycochea-Robles, Diane Lacaille
• Extended report: Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis (11 March, 2011)

  Tracey E Toms, Vasileios F Panoulas, Jacqueline P Smith, Karen M J Douglas, Giorgos S Metsios, Antonios Stavropoulos-Kalinoglou, George D Kitas
• Extended report: Hand osteoarthritis and MRI: development and first validation step of the proposed Oslo Hand Osteoarthritis MRI score (24 March, 2011)

  Ida K Haugen, Siri Lillegraven, Barbara Slatkowsky-Christensen, Espen A Haavardsholm, Sølve Sesseng, Tore K Kvien, Désirée van der Heijde, Pernille Bøyesen
• Extended report: The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study (17 March, 2011)

  Naomi B Klarenbeek, Melek Güler-Yüksel, Sjoerd M van der Kooij, K Huub Han, H Karel Ronday, Pit J S M Kerstens, Patrick E H Seys, Tom W J Huizinga, Ben A C Dijkmans, Cornelia F Allaart
• Extended report: The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients (11 March, 2011)

  Ragnar Gunnarsson, Øyvind Molberg, Inge-Margrethe Gilboe, Jan Tore Gran, PAHNOR1 Study Group*
• Extended report: Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins (15 March, 2011)

  Lætitia Laurent, Cyril Clavel, Olivia Lemaire, Florence Anquetil, Martin Cornillet, Laurent Zabraniecki, Leonor Nogueira, Bernard Fournié, Guy Serre, Mireille Sebbag
• Extended report: Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy (2 May, 2011)

  Sarah Hewlett, Nick Ambler, Celia Almeida, Alena Cliss, Alison Hammond, Karen Kitchen, Bev Knops, Denise Pope, Melissa Spears, Annette Swinkels, Jon Pollock
• Extended report: Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases (2 May, 2011)

  Carla G S Saad, Eduardo F Borba, Nadia E Aikawa, Clovis A Silva, Rosa M R Pereira, Ana Luisa Calich, Julio C B Moraes, Ana C M Ribeiro, Vilma S T Viana, Sandra G Pasoto, Jozelio F Carvalho, Ivan L A França, Lissiane K N Guedes, Samuel K Shinjo, Percival D Sampaio-Barros, Maria T Caleiro, Celio R Goncalves, Ricardo Fuller, Mauricio Levy-Neto, Maria do Carmo S Timenetsky, Alexander R Precioso, Eloisa Bonfa
• Extended report: Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries (2 May, 2011)

  Tanja A Stamm, Malin Mattsson, Carina Mihai, Juliane Stöcker, Alexa Binder, Bettina Bauernfeind, Georg Stummvoll, Gunvor Gard, Roger Hesselstrand, Gunnel Sandqvist, Oana Draghicescu, Ana Maria Gherghe, Malina Voicu, Klaus P Machold, Oliver Distler, Josef S Smolen, Carina Boström
• Concise report: Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis (6 March, 2011)

  Turid Heiberg, Cathrine Austad, Tore K Kvien, Till Uhlig
• Concise report: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study (1 February, 2011)

  Amelia Ruffatti, Teresa Del Ross, Manuela Ciprian, Maria T Bertero, Sciascia Salvatore, Salvatore Scarpato, Carlomaurizio Montecucco, Silvia Rossi, Paola Caramaschi, Domenico Biasi, Andrea Doria, Mariaelisa Rampudda, Nuzzo Monica, Fabio Fischetti, Ugo Picillo, Antonio Brucato, Elisa Salvan, Pengo Vittorio, Pierluigi Meroni, Angela Tincani, Antiphospholipid Syndrome Study Group of the Italian Society of Rheumatology
• Concise report: The presence of total knee or hip replacements due to osteoarthritis enhances the positive association between hand osteoarthritis and atherosclerosis in women: the AGES–Reykjavik study (1 March, 2011)

  Helgi Jonsson, Gudrun P Helgadottir, Thor Aspelund, Gudny Eiriksdottir, Sigurdur Sigurdsson, Kristin Siggeirsdottir, Thorvaldur Ingvarsson, Tamara B Harris, Lenore Launer, Vilmundur Gudnason
• Concise report: Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study (22 February, 2011)

  Fiona McQueen, Richard Lloyd, Anthony Doyle, Elizabeth Robinson, Maria Lobo, Melissa Exeter, William J Taylor, Peter Jones, Ian R Reid, Nicola Dalbeth
• Concise report: Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis (1 March, 2011)

  Benjamin A Fisher, Darren Plant, Monica Brode, Ronald F van Vollenhoven, Linda Mathsson, Deborah Symmons, Karin Lundberg, Johan Rönnelid, Patrick J Venables
• Concise report: Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study (15 March, 2011)

  M F Bakker, J W G Jacobs, P M J Welsing, S A Vreugdenhil, C van Booma-Frankfort, S P Linn-Rasker, E Ton, F P J G Lafeber, J W J Bijlsma
• Concise report: Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis (6 March, 2011)

  Elizabeth N Le, Fredrick M Wigley, Ami A Shah, Francesco Boin, Laura K Hummers
• Concise report: Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study (17 March, 2011)

  I-H Song, F Heldmann, M Rudwaleit, H Haibel, A Weiß, J Braun, J Sieper
• Concise report: Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level (15 March, 2011)

  Marwin Gutierrez, Emilio Filippucci, Fausto Salaffi, Luca Di Geso, Walter Grassi